US 9844540
Combination therapies for treating cancer
granted A61KA61K31/435A61K31/438
Quick answer
US patent 9844540 (Combination therapies for treating cancer) held by RedHill Biopharma Ltd. expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- RedHill Biopharma Ltd.
- Grant date
- Tue Dec 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/435, A61K31/438, A61K31/4409, A61K31/495